ArticleFish physiology and biochemistry2025
Efficacy of dietary Ceratonia silique and Zingiber offcinale on the immune-antioxidant-signaling pathways, growth, physiological response, and ammonia resistance in Oreochromis niloticus reared under unchanged water.
Article in Fish physiology and biochemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Prioritizing water management and maintaining its quality for as long as possible, while lowering related stressors, are crucial for sustainable aquaculture. To achieve this equilibrium, enriched aquafeed with natural immunostimulants is essential to success. In this trend, 6 weeks feeding trial was conducted to evaluate the effects of Ceratonia siliqua syrup (CSS) and Zingiber officinale powder (ZOP) in Nile tilapia (Oreochromis niloticus) reared under a zero-water exchange. The immune-antioxidant, growth, physiological responses, and the antioxidant/inflammatory pathways-associated genes as well as ammonia tolerance were evaluated. Fish (weighing 25.85 ± 1.42 g) were randomly housed into six groups (n = 30 fish/group; ten fish/replicate; three replicates/group). The control group was fed a basal diet without any additives. The second (CSS1.25) group was fed a diet supplemented with 1.25% CSS. The third (ZOP0.5) and fourth (ZOP1) groups were fed diets supplemented with 0.5 and 1% ZOP. The fifth (CSS1.25 + ZOP0.5) and sixth (CSS1.25 + ZOP1) groups were fed diets supplemented with 1.25% CSS and 0.5 or 1% ZOP. All treatments were kept without water exchange for 6 weeks. Findings revealed the most notable improvement (P < 0.05) in growth rate (final body weight and specific growth rate) and survival rate in fish fed with dietary ZOP and CSS1.25 + ZOP0.5 diets. Hepato-renal markers (alanine and aspartate aminotransferases, urea, glucose, and cortisol) and lipid peroxides (malonaldehyde) were declined by CSS and/or ZOP diets. Immuno-antioxidants (immunoglobulin M, lysozyme, superoxide dismutase (SOD), and reduced glutathione) were significantly boosted (P < 0.05) in the ZOP1 and CSS1.25 + ZOP0.5 groups. In addition, CSS and/or ZOP diets markedly (P < 0.05) upregulated antioxidant-linked genes (SOD and glutathione peroxidase) and downregulated the stress gene (heat shock protein 70) and pro-inflammatory cytokines (interleukin-1β and tumor necrosis factor-alpha). In addition, CSS and/or ZOP diets decreased fish mortality during ammonia stress. The ZOP1 diet was significantly reported of having the best outcomes (P < 0.05) throughout the measured indices. Overall, our findings demonstrate that dietary ZOP and CSS at the optimum doses can improve growth, immune response, and physiological functions of O. niloticus reared in stressful conditions (unchanged water) for the sustainable aquaculture industry.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.